Phytopharmaceutical

Sun Pharma's AQCH - Phytopharmaceutical Drug Goes into Phase 2 Clinical Trial for COVID-19 Treatment

Sun Pharma got approval from Drugs Controller General of India (DCGI) for conducting phase two clinical trial in April. The clinical trial will be conducted across 12 centres in India on 210 patients with a duration of 10 days.